- Report
- January 2025
- 82 Pages
Vietnam
From €3327EUR$3,500USD£2,795GBP
- Report
- October 2023
- 128 Pages
Europe
From €3803EUR$4,000USD£3,195GBP
- Report
- February 2024
- 111 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- April 2023
- 117 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- January 2024
North America
From €1426EUR$1,500USD£1,198GBP
- Report
- February 2024
- 91 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- August 2023
- 113 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- August 2023
- 115 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- September 2022
- 93 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- August 2024
- 248 Pages
China
From €3803EUR$4,000USD£3,195GBP
- Report
- August 2024
- 104 Pages
China
From €1711EUR$1,800USD£1,438GBP
- Report
- November 2021
- 747 Pages
Global
From €3803EUR$4,000USD£3,195GBP
- Report
- November 2021
- 392 Pages
Global
From €2852EUR$3,000USD£2,396GBP

The Liposome market is a subset of the Drug Delivery market, which focuses on the development of technologies to deliver drugs to their intended targets. Liposomes are microscopic vesicles composed of phospholipids, which are used to encapsulate drugs and deliver them to the desired location in the body. Liposomes are advantageous due to their ability to protect drugs from degradation, increase drug solubility, and target specific cells.
Liposome-based drug delivery systems are used in a variety of therapeutic areas, including oncology, infectious diseases, and cardiovascular diseases. Liposomes are also used in the development of vaccines, as they can be used to deliver antigens to the body and induce an immune response.
Notable companies in the Liposome market include Lipoxen Technologies, Lipomed, and Liposome Company. Other companies in the market include Avanti Polar Lipids, Bio-Techne, and InnoBio. Show Less Read more